ScholarWorks@Hanyang University

Browsing by Hong, Jun HwaAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 6 of 6

SCIESCOPUS
Effectiveness and Safety of Evogliptin in Patients With Type 2 Diabetes Mellitus: A Multicenter, Prospective, Observational StudyGo to Linkopen access

Hong, Jun Hwa; Yu, Sung Hoon; Baek, Ki-hyun; Yu, Jaemyung; Lee, Seung Jin; Kim, Hyung-wook; Park, Kang Seo; Kim, Jung Han; Min, Kyungwan; Lee, Yong Hwan, et al.

ArticleIssue Date2026CitationDIABETES OBESITY & METABOLISM, v.28, no.5, pp 4112 - 4120PublisherWILEY
SCIESCOPUS
Effectiveness of single-pill combination olmesartan/amlodipine/hydrochlorothiazide therapy in patients with apparent resistant hypertensionGo to Linkopen access

Oh, Jaewon; Kim, Wonho; Kim, Gee-Hee; Kim, Hack-Lyoung; Park, Sang-Don; Min, Kyung Wan; Hyun, Dongkeun; Hong, Jun Hwa; Lim, Soo; Bae, Ji-Hwan, et al.

ArticleIssue Date2025CitationJOURNAL OF HUMAN HYPERTENSION, v.39, no.9, pp 675 - 678PublisherSPRINGERNATURE
SCIESCOPUS
Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III studyGo to Linkopen access

Hong, Jun Hwa; Kim, Myung Jin; Min, Kyung Wan; Won, Jong Chul; Kim, Tae Nyun; Lee, Byung-Wan; Kang, Jun Goo; Kim, Jae Hyeon; Park, Jung Hwan; Ku, Bon Jeong, et al.

ArticleIssue Date2025CitationDIABETES OBESITY & METABOLISM, v.27, no.1, pp 81 - 91PublisherWILEY
SCIESCOPUS
Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trialGo to Link

Kim, So Ra; Hong, Jun Hwa; Kim, Sin Gon; Kim, Soo-Kyung; Kwon, Hyuk-Sang; Moon, Jun Sung; Park, Jung Hwan; Yu, Jae Myung; Cha, Bong-Soo; Lee, Byung-Wan

ArticleIssue Date2026CitationDIABETES OBESITY & METABOLISM, v.28, no.4, pp 3305 - 3316PublisherWILEY
SCIESCOPUSKCI
Efficacy and Safety of High-Dose Pioglitazone as Addon Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled TrialGo to Linkopen access

Hong, Jun Hwa; Han, Kyung Ah; Hwang, You-Cheol; Hong, Eun-Gyoung; Kim, Hae Jin; Lee, Chang Beom; Cho, Ho Chan; Won, Jong Chul; Kim, Hun-Sung; Kim, Eui-Hyun, et al.

ArticleIssue Date2026CitationDIABETES & METABOLISM JOURNAL, v.50, no.2, pp 321 - 330PublisherKOREAN DIABETES ASSOC
SCIESCOPUS
Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-Controlled StudyGo to Linkopen access

Cho, Yun Kyung; Kim, Kyung-Soo; Lee, Byung-Wan; Hong, Jun Hwa; Yu, Jae Myung; Lim, Soo; Kim, Ye An; Lee, Chang Beom; Kim, Sang Soo; Kwak, Soo Heon, et al.

ArticleIssue Date2024CitationClinical Therapeutics, v.46, no.9, pp 662 - 669PublisherElsevier Inc.
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

COPYRIGHT © 2024 HANYANG UNIVERSITY.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어